Carcinoma of the anterior urethra is a sinister complication of bladder cancer, which may frequently be followed by dissemination of the disease and death (Deming & Lindskog 1944 , Millin 1948 , Riches & Cullen 1951 , Baird et al. 1955 , Boreham 1956 , King 1964 , Kaplan et al. 1967 , Beebe & Persky 1969 . Early studies suggested that this complication was uncommon. Ashworth (1956) observed only 54 urethral tumours in 1307 patients of both sexes (an overall incidence of 4.1 %). In 50 men, the disease involved the posterior urethra in 48 cases, and there was extension to the anterior urethra in only 7 cases. Urethral involvement appeared to be more common with multiple papillary lesions (8.4%) than with invasive cancer (1.8%) in the bladder, and in 74% of cases there was tumour growth around the internal meatus of the bladder. Cordonnier & Spjut (1962) observed 7 instances of anterior urethral carcinoma in 142 cases of bladder cancer (an incidence of 4.02 %), and since 5 patients died 'rather promptly', they confirmed that this should be considered a serious complication. They also noted that although it was more apt to appear in patients with multiple papillary low grade lesions, it could occur as well with more highly malignant lesions, and they concluded that it was not possible to predict in which patients urethral carcinoma was most likely to develop.
At the Royal Marsden Hospital, Gowing (1960) demonstrated a high incidence (18%) of in-situ urethral carcinoma in 33 patients dying with bladder cancer, and also showed that the disease occurred as a widespread multicentric change in the urethral epithelium. These observations have been reflected in the therapeutic approach to these tumours at this hospital, and simultaneous one-stage cysto-urethrectomy has been performed for all extensive multiple bladder tumours which encroached on the bladder neck or involved the posterior urethra. Urethral tumours developing after previous cystectomy were treated by early secondary urethrectomy. Urethral fulguration was condemned, since it was believed that this could destroy the delicate basement membrane which separated the tumour from the large I Present address: St Bartholomew's Hospital, London ECI vascular spaces of the corpus spongiosum and thus encourage dissemination of the disease.
In this report, three aspects of urethral cancer are considered: (1) Additional pathological studies are recorded, and the incidence of in-situ urethral carcinoma is related to the type of the original bladder tumour. (2) Four cases are then described, which illustrate the dangers associated with conservative treatment of these tumours.
(3) The clinical results of urethrectomy are reported in 44 cases
Investigation ofNecropsy Cases
As an extension of previously reported studies (Gowing 1960) , 101 urethras from male patients dying with bladder cancer were examined after fixation with 4-5 ml of formol-saline immediately after death, and the findings were compared with those in 78 control patients dying with malignancy not involving the urothelium. Evidence of in-situ urethral carcinoma was found in 19 (19%) of 101 patients dying of bladder cancer, and in only 1 (0.8 %) of 78 cases in the control group (a patient dying of astrocytoma).
Further analysis (Table 1) showed that in-situ carcinoma was present in 9 (31 %) of 29 patients whose original bladder tumours had been multiple, papillary, and generally well or moderately well differentiated, as compared to 10 (15.5%) of 65 patients whose bladder tumours had been single, solid, and poorly differentiated or anaplastic. In-situ carcinoma was not found in 3 patients with squamous cell carcinoma, in 1 case with sarcoma of bladder, or in 2 patients with carcinoma of the renal pelvis.
These observations confirm the findings of the previous study, that changes of in-situ carcinoma may be found in 19 % of male patients dying with bladder cancer. In addition, they demonstrate that urethral in-situ carcinoma is twice as common when the original bladder tumour is multiple and papillary, as opposed to single, solid and poorly differentiated.
Case Reports: Results ofLocal Interference with Anterior Urethral Tumours Case 1 0 G, a farmer aged 61, first develope4 papillary bladder tumours in 1943, and these were repeatedly fulgurated at another hospital. In 1952, partial cystectomy was performed, when histological examination showed invasive transitional cell carcinoma of average grade. The tumour recurred around the bladder neck, and he was referred to the Royal Marsden Hospital in 1953. Total cystectomy and ureterocolic diversion was performed in July 1953 and histological examination showed extensive poorly differentiated papillary transitional cell carcinoma. In January 1954 he developed urethral bleeding, and a recurrence in the Case 4 H H, a wood carver aged 53 years, presented at another hospital in 1961 with multiple papillary bladder tumours, which were removed by transvesical excision and diathermy; histological examination showed papillary differentiated transitional cell carcinoma.
Small recurrences were controlled by fulguration at three monthly intervals for the next three years. In April 1964, extensive papillary growth had extended over most of the bladder, and total cystectomy with ureterocolic anastomosis was performed; pathological examination showed extensive multifocal papillary differentiated transitional cell carcinoma. with no evidence of invasion. He remained well thereafter until September 1968, when urethral bleeding occurred. Urethroscopy showed a papillary tumour about the size of a hazel nut in the anterior urethra, which protruded from the meatus; this was excised with diathermy, and histological examination showed papillary differentiated transitional cell carcinoma, with microscopic penetration of the basement membrane in one small area only. Follow-up urethroscopy showed no 'evidence of recurrence until November 1969, when a small sessile growth on the anterior wall of the urethra 1-2 inches (2.5-5.0 cm) from the external meatus was diathermied. A further small anterior urethral tumour was fulgurated in January 1970. At review urethroscopy in April 1970 no further tumour was seen. In November 1970. he coughed up blood. Chest X-ray showed multiple bilateral pulmonary metastases. He was referred to the Royal Marsden Hospital for chemotherapy, and after transient improvement he died in April 1971. Postmortem examination showed large necrotic secondary deposits in both lungs.
These 4 cases illustrate the lethal potential of tumours in the anterior urethra, and demonstrate the dangers that may be associated with local interference.
Clinical Results of Urethrectomy Between 1951 and 1971, over 300 radical cystectomies were performed for bladder cancer at the Royal Marsden Hospital. In 74 cases (25 %) urothelial tumours appeared elsewhere in the urinary drainage tract, either before, after, or at the time of cystectomy (Table 2) .
Forty-nine urethral tumours were seen: 22 were treated by one-stage cysto-urethrectomy; 20 developed after previous cystectomy and were treated by secondary urethrectomy; 5 were inoperable, and 2 occurred in women.
One-stage cysto-urethrectomy was performed for extensive multiple papillary bladder tumours, involved which had spread to involve the bladder neck or prostatic urethra, since it was believed that urethral recurrence was most likely to occur in these cases after cystectomy. In Table 3 , the characteristics of the original bladder tumours in patients who had one-stage cysto-urethrectomy are compared with those in patients who underwent secondary urethrectomy for urethral recurrence after previous cystectomy, or who developed inoperable urethral recurrence. It may be observed that although urethral recurrence was more common after previous multiple papillary bladder tumours, it also occurred after cystectomy for single, solid tumours, and the majority of the original bladder tumours were poorly differentiated. The average survival of 22 cases after one-stage cysto-urethrectomy, and of 20 cases after secondary urethrectomy are related to the urethral pathology in Table 4 . In both groups of cases, there is little difference in survival times when no tumour or in-situ carcinoma is found in the urethra; by contrast, the presence of invasive carcinoma in the urethra was associated with a very poor prognosis, with an average survival of only six months for 11 cases. One remarkable patient stands alone in this group, who survived for almost fifteen years after excision of an invasive urethral cancer and then died of a myocardial infarction, when no tumour was found at autopsy. In women, the urethra was always removed with the bladder. In 2 cases there was evidence of carcinomatous change in the urethral epithelium. One patient with widespread poorly differentiated transitional cell carcinoma died after thirteen months with metastases; the second patient, with in-situ urethral carcinoma, is alive and well forty-four months after cysto-urethrectomy.
Discussion
The post-mortem studies have confirmed the findings previously reported in a smaller series of cases (Gowing 1960 ) that in-situ urethral carcinoma was present in 19o% of men dying with bladder cancer, and, in addition, have demonstrated that malignant change in the urethral epithelium is twice as common with multiple papillary bladder tumours, as compared to single, solid anaplastic tumours. This finding is confirmed in life by analysis of the cases which developed urethral tumours after previous cystectomy, and required secondary urethrectomy. Again, urethral tumours most commonly followed multiple papillary bladder tumours. Nevertheless, in about one-third of cases, the original bladder tumour had been single, solid, and poorly differentiated. This indicates that the cystoscopic and histological characteristics of the primary bladder tumours, taken alone, do not provide sufficient evidence on which to base the decision as to whether or not urethrectomy should be combined with cystectomy as a onestage procedure.
The 4 case reports demonstrate the lethal potential of anterior urethral carcinoma. In these cases, dissemination of the disease followed inadequate local surgery or diathermy, and it seems very likely that this could be due to spread via the vascular spaces of the corpus spongiosum. The great difference in prognosis after urethrectomy between in-situ and invasive carcinoma in the anterior urethra provides strong evidence in favour of complete excision of the urethra at an early stage of the disease, rather than risking penetration of the delicate basement membrane by local interference.
Urethrectomy is a significant addition to cystectomy and urinary diversion, which adds to the time for the operation and to the morbidity. At the Memorial Hospital, New York, most high stage and many low stage bladder tumours are treated by one-stage radical cysto-urethrectomy (Whitmore & Mount 1970) . We would suggest that all cases with multiple papillary tumours should be treated by one-stage cysto-urethrectomy, but that some method of case selection is needed for patients undergoing cystectomy for single, solid bladder tumours. This might be based upon detection of in-situ change in the urethral epithelium prior to cystectomy, and the soluble urethral swab cytological technique described by Trott (1971) would appear to be very suitable for this purpose. This investigation is currently being evaluated as part of the work up before cystectomy in men, and it is hoped that this may permit accurate selection of cases in which urethrectomy should be combined with radical cystectomy. In women, the urethra should be completely removed in every case. Summary Three aspects of urethral carcinoma occurring with bladder cancer are considered. In a postmortem study, in-situ carcinoma was found in 19% of 101 male patients dying with bladder tumours, and this change was twice as common with multiple papillary tumours as compared to single, solid anaplastic lesions in the bladder. Four cases are described which illustrate the dangers which are associated with diathermy of anterior urethral tumours. The results of urethrectomy in 49 male patients are analysed, which were done between 1951 and 1971 in a series of more than 300 cystectomies: 22 patients underwent one-stage cysto-urethrectomy, and in 20 cases secondary urethrectomy was performed for urethral recurrence following cystectomy. Prognosis was closely related to the presence of invasion in the urethral tumour, and when present, average survival was only 6 months for 11 of 12 cases.
It is concluded that when cystectomy is perfotmed for multiple papillary bladder tumours, the urethra should be removed simultaneously as a one-stage cysto-urethrectomy. When the bladder is removed for single anaplastic tumours, urethral cytology may be helpful in selecting cases for cysto-urethrectomy. Urethral recurrence after previous cystectomy is clearly a serious and lifethreatening complication, which should be treated by early secondary urethrectomy.
Mr B G F Shepheard (Royal Marsden Hospital, London SW3)
Alpha-fetoprotein and Teratomas of the Testis Serum alpha-fetoprotein (AFP) has been extensively studied in primary hepatocellular carcinoma, a disease less common in this country than teratoma. Yet very little research has been directed to its clinical use in the testicular neoplasms. The purpose of this paper is to stimulate interest in this protein by presenting preliminary findings and indicating possible clinical applications.
Alpha-fetoprotein is an embryo-specific protein and does not occur in the adult except in pathological states. It is an alpha-globulin, and in the early embryo it is probably the dominant serum protein, being replaced later by albumin, which it resembles in physicochemical properties. In the embryo it is produced at first by the yolksac and later by the liver. After birth, the serum level falls rapidly to the adult level, which is so low that it is difficult to detect even with the more sensitive assays. The only normal state with a raised alphafetoprotein in. adults is pregnancy; the protein crosses the placental barrier. Occurrence Apart from in primary hepatoma, it has been found in teratomas of all types, viral hepatitis, liver regeneration (though not in cirrhosis) and in secondary liver tumours. At a serum level about 250 times the very low normal, it is diagnostic of hepatoma or teratoma. At lower levels, the other possible diagnoses have to be entertained, but there is unlikely to be confusion in the young man with a testicular tumour. Detection and assay: Detection is by immunochemical methods using specific anti-alphafetoprotein sera. Most commonly, agar gel precipitation is used, but this is not as sensitive as the newer immunoassays, using isotopes. At present, the assays for the Royal Marsden Hospital are done by Dr J Kohn at Queen Mary Hospital, Roehampton, using a precipitation method, but shortly a radioimmunoassay is to be introduced. It is hoped that this type of assay will detect at lower levels and produce quantitative results.
Occurrence in teratoma of the testis: In a masterly review, Abelev (1971) , collecting cases from the literature and adding cases of his own, has shown that about 45% of teratomas of the testis are positive at diagnostic levels, using agar gel precipitation. Taking his own negative cases, he found 75 % of these were positive using the more sensi-
